Literature DB >> 18021702

[Developing a new animal model of temporal lobe epilepsy].

Lionel Carmant1.   

Abstract

Epilepsy affects 1-2 % of the population. For 30 % of these patients, their syndrome will be refractory to medical treatment. To improve our understanding and treatment of the epilepsies, we need to develop clinically relevant animal models. As temporal lobe epilepsy is often preceded by prolonged febrile seizures and in our population associated with a focal cortical dysplasia, we hypothesised that an underlying predisposing anatomical lesion would predispose individuals to develop prolonged febrile seizures and that temporal lobe epilepsy would later develop. As predicted, all the lesioned animals developed prolonged febrile seizures, while all other control groups only showed simple febrile seizures. After a latent period, 86 % of the animals who had experienced a prolonged seizure developed spontaneously recurrent limbic seizures. We now need to understand the anatomical and electrophysiological changes underlying this new epilepsy model to try and develop more effective treatments for the condition.

Entities:  

Mesh:

Year:  2007        PMID: 18021702     DOI: 10.1051/medsci/20072311929

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  3 in total

1.  Hyperthermia-Induced Febrile Seizures Have Moderate and Transient Effects on Spatial Learning in Immature Rats.

Authors:  Nawel Yagoubi; Yosra Jomni; Mohsen Sakly
Journal:  Behav Neurol       Date:  2015-04-30       Impact factor: 3.342

2.  Atypical febrile seizures, mesial temporal lobe epilepsy, and dual pathology.

Authors:  Nathalie T Sanon; Sébastien Desgent; Lionel Carmant
Journal:  Epilepsy Res Treat       Date:  2012-04-23

3.  Early-life stress is associated with gender-based vulnerability to epileptogenesis in rat pups.

Authors:  Sébastien Desgent; Sandra Duss; Nathalie T Sanon; Pablo Lema; Maxime Lévesque; David Hébert; Rose-Marie Rébillard; Karine Bibeau; Michèle Brochu; Lionel Carmant
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.